Streetbeat News

Analyst Ratings

CVNA

Zack's Tech Innovators has mentioned Carvana (CVNA) in their discussions, which could potentially influence the stock's performance.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 11:56 am

ESPR

Esperion Therapeutics (NASDAQ:ESPR) has received five bullish analyst ratings in the last quarter, with an average 12-month price target of $13.4, a significant increase from the previous average of $7.75. No bearish or neutral ratings were observed.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:55 am

NBIX

Over the past 3 months, 13 analysts have published their opinion on Neurocrine Biosciences (NASDAQ:NBIX) stock. The average 12-month price target for the stock is $120.92, with a high of $150.00 and a low of $96.00. The average price target has increased by 2.65% over the past month.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:55 am

PEN

Analysts from Truist Securities and Needham have reiterated their positive outlook on Penumbra, Inc. (NYSE:PEN) despite product launch delays. The company's Q2 results beat estimates and it raised its 2023 total revenue guidance to $1.05 billion-$1.07 billion. However, PEN shares are expected to face pressure due to a delay in Thunderbolt approval/launch. Both analysts anticipate margin expansion for PEN in 2H and expect the company to deliver EPS growth above its revenue growth.

Portfolio Pulse from Nabaparna Bhattacharya

August 04, 2023 | 11:55 am

EXEL

Exelixis (NASDAQ:EXEL) has received 8 analyst ratings in the last quarter, with 5 being somewhat bullish and 3 indifferent. The average price target for the stock is $23.88, which is higher than its current price of $20.255. This average has increased by 13.71% from the previous average price target of $21.00.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:54 am

INCY

Incyte (NASDAQ:INCY) has received various ratings from 10 analysts over the last quarter, with an average price target of $81.6, indicating potential upside from the current price of $65.48. The average price target has increased by 6.21% over the past month.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:54 am

NCLH

Susquehanna analyst Christopher N. Stathoulopoulos downgraded Norwegian Cruise Line Holdings Ltd (NYSE:NCLH) to Neutral from Positive at a price target of $17 following Q2 FY23 results. Despite reporting strong Q2 sales growth and beating analyst consensus, the company's adjusted EBITDA is expected to take some time to return to pre-pandemic levels. Barclays also lowered the price target to $21 from $22, maintaining an Equal-Weight rating.

Portfolio Pulse from Lekha Gupta

August 04, 2023 | 11:54 am

BPMC

In the last quarter, 15 analysts have provided ratings for Blueprint Medicines (NASDAQ:BPMC), with 6 being bullish, 3 somewhat bullish, 5 indifferent, and 1 somewhat bearish. The company has an average 12-month price target of $69.6, which has increased by 20.37% over the past month.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:53 am

AXTA

Axalta Coating Sys (NYSE:AXTA) has received various analyst ratings in the last quarter, with 3 bullish, 1 somewhat bullish, 2 indifferent, and 1 somewhat bearish. Over the past 3 months, 7 analysts have offered 12-month price targets for Axalta, with an average price target of $35.0, a high of $38.00, and a low of $31.00. The average price target has increased by 7.69% over the past month.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:53 am

BUD

A significant investor has taken a bullish stance on Anheuser-Busch InBev (NYSE:BUD), with 66% of recent trades being bullish and 33% bearish. The majority of trades are puts, with a total amount of $553,653, and calls amounting to $232,900. Whales have been targeting a price range from $45.0 to $60.0 for Anheuser-Busch InBev over the last 3 months. The current price of BUD is down -1.21% at $56.16. Morgan Stanley has upgraded its action to Overweight with a price target of $68.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 11:53 am